|Mr. Adam D. Gridley||Pres & Director||817.73k||N/A||1972|
|Mr. Jonathan I. Lieber||Interim Chief Financial Officer||503.69k||N/A||1970|
Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
Histogenics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.